VitroGro® ECM is a topically applied healing promoter for the treatment of chronic wounds of all severities that is designed to be used with standard care.
VitroGro® ECM is different from other products because it targets the breakdown of the early stages of normal healing that occurs in chronic wounds by combining the benefits of a vitronectin based extracellular matrix scaffold with the growth promoter IGF-I. Native vitronectin and IGF-I are key proteins that promote the critically important attachment and growth of skin cells in the early stages of normal wound healing. VitroGro® ECM harnesses these beneficial properties to promote healing in chronic wounds that have stalled or delayed healing.
The vitronectin segment of the VitroGro® fusion protein binds to the wound bed and provides sites for attachment of skin cells and the IGF-I growth factor promotes the migration and proliferation of attached skin cells.
Pre-clinical testing shows that the combined effect of both these components is greater than the affect of each component individually which highlights the importance of a targeted multifaceted approach to the reinstatement of healing in chronic wounds.